Medindia

X

TB Treatment Time may be Reduced by Inhalable Dry Powder Antibiotic

by Kathy Jones on  November 20, 2010 at 8:39 PM Drug News   - G J E 4
An inhalable dry powder antibiotic that when used alone or with current treatments may significantly reduce treatment for tuberculosis (TB) and multi-drug resistant TB, new research has indicated.
 TB Treatment Time may be Reduced by Inhalable Dry Powder Antibiotic
TB Treatment Time may be Reduced by Inhalable Dry Powder Antibiotic
Advertisement

Lead researcher J'aime Manion and her colleagues from the University of Colorado developed the inhalable dry powder, comprised of fine particles of antibiotics. These particles are targeted to the deep lung where TB enters in early stages of infection. The goal of this method is to distribute a larger fraction of antibiotic to protected TB lesions that are difficult to access by current treatments.

Advertisement
"Combining this novel treatment with more traditional methods may increase the targeted dose to the lung airspace and tissue, potentially reducing treatment time and systemic side effects," said Manion.

"As an inhalable powder, it eliminates the storage, disposal and contamination challenges that developing countries face with a needle delivery method."

The research will be presented at the 2010 International Pharmaceutical Federation (FIP) Pharmaceutical Sciences World Congress (PSWC) in association with the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition.

Source: ANI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All